drugset / Trial / NCT00681798

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

NCT00681798

Phase 1 Completed 8 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to define th Maximum Tolerated Dose (MTD) and the recommended dose (RD) of ZD6474 in combination with a fixed standard dose of gemcitabine and capecitabine

Timeline

Start
2006-07
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vandetanib Small molecule 100 mg
Comparator Vandetanib Small molecule 300 mg